The biopharmaceutical company AstraZeneca announced it will $50 billion into the United States, with plans to open several ...

AstraZeneca, the UK's largest listed company by market value, reported revenue growth of 11% to $14.46 billion for the ...

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

AstraZeneca says it’ll invest $50 billion in the United States by 2030 as President Donald Trump threatens steep tariffs on drug imports. The pharmaceutical giant Astra Zeneca has announced it's to ...

AstraZeneca PLC (NASDAQ: AZN) ranks among the stocks to benefit from an onshoring boom. AstraZeneca PLC (NASDAQ:AZN) ...

The investment will fund a new drug manufacturing facility in Virginia, and expand research and development in at least 5 ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States by 2030 amid Donald ...

AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of ...

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming ...

The proposed manufacturing facility in Virginia would be the linchpin of a $50 billion plan that AstraZeneca announced. It ...

British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump ...